AMGN

Amgen Inc. News Headlines

$159.19
*  
0.63
0.4%
Get AMGN Alerts
*Delayed - data as of Mar. 4, 2015  -  Find a broker to begin trading AMGN now
Exchange: NASDAQ
Industry: Health Care
Community Rating:
 
 
Symbol List Views
FlashQuotes InfoQuotes
Stock Details
Summary Quote Real-Time Quote After Hours Quote Pre-market Quote Historical Quote Option Chain
CHARTS
Basic Chart Interactive Chart
COMPANY NEWS
Company Headlines Press Releases Market Stream
STOCK ANALYSIS
Analyst Research Guru Analysis Stock Report Competitors Stock Consultant Stock Comparison
FUNDAMENTALS
Call Transcripts Annual Report Income Statement Revenue/EPS SEC Filings Short Interest Dividend History
HOLDINGS
Ownership Summary Institutional Holdings Insiders
(SEC Form 4)
 Save Stocks
Viewing
Filtered By
Ordered By
Case Builds For Owning Amgen
3/4/2015 1:39:00 PM - Seeking Alpha


Amgen Still In Play With Endeavor To Expand Kyprolis
3/4/2015 10:10:00 AM - Seeking Alpha


I'm Staying Long On Amgen, But Not Buying Shares
3/4/2015 9:22:00 AM - Seeking Alpha


Amgen: The Best Biotech Stock You Don't Own
3/3/2015 5:04:00 PM - Seeking Alpha


Amgen-Celimmune Tie Up for Autoimmune Disorder Drug - Analyst Blog
3/3/2015 4:10:00 PM - Zacks.com


Ligand Pharmaceuticals Weakens The Bear Case
3/3/2015 11:17:00 AM - Seeking Alpha


10 Dandy Dividend Healthcare Dogs Hail 14% February Upsides
3/3/2015 6:28:00 AM - Seeking Alpha


Amgen's Kyprolis Fares Better than Velcade in Study - Analyst Blog
3/2/2015 3:02:00 PM - Zacks.com


Amgen To Present At Cowen And Co Health Care Conference; Webcast At 2:50 PM ET
3/2/2015 1:54:00 PM - RTT News


PDL BioPharma, Inc. (PDLI) Ex-Dividend Date Scheduled for March 03, 2015
3/2/2015 9:00:07 AM - NASDAQ.com News


Amgen's Long Case Strengthens After Kyprolis Data
3/2/2015 8:41:00 AM - Seeking Alpha


AMGN's Kyprolis Better Than Rival, KOOL Put On Notice, XON Inks Fruity Deal
3/2/2015 1:42:00 AM - RTT News


Amgen Multiple Myeloma Drug Kyprolis Tops Rival in Study
3/1/2015 10:25:00 PM - TheStreet


Trial Shows Superiority Of Kyprolis Over Velcade In Relapsed Multiple Myeloma
3/1/2015 7:16:00 PM - RTT News


Some Companies Are More Wonderful Than Others
3/1/2015 5:02:00 AM - Seeking Alpha


Amgen's Kyprolis Under EU Review - Analyst Blog
2/28/2015 7:36:00 PM - Zacks.com


Seeking Alpha's Biotech Weekly: Achillion Overdone, Sanofi's Toujeo A Go, And More
2/27/2015 4:00:00 PM - Seeking Alpha


Value Oriented Investors Should Consider Amgen
2/27/2015 3:05:00 PM - Seeking Alpha


Noteworthy ETF Inflows: IYH, MRK, GILD, AMGN
2/27/2015 10:54:42 AM - BNK Invest


A Quick Review Of The Asthma Market
2/27/2015 10:26:00 AM - Seeking Alpha


STAR Lights Up CYTX, NVAX Awaits Catalysts, VTAE Thrashed, CMRX On Watch
2/27/2015 12:02:00 AM - RTT News


Amgen Reports Encouraging Late-Stage Data on AMG 416 - Analyst Blog
2/26/2015 11:20:00 AM - Zacks.com


AMGN Study Meets Goal, BRLI Hits New High, DPRX On Watch, GMED Opens Wallet
2/25/2015 11:26:00 PM - RTT News


Making Money With Charles Payne: 02/25/15
2/25/2015 6:00:00 PM - Fox Business


Third Point reduces stake in Dow Chemical
2/25/2015 2:05:00 PM - Market Realist